Clinical and Experimental Human Genomics
Clinical and Experimental Human Genomics
Introduction

The Clinical and Experimental Human Genomics group (CEHG) is integrated in a healthcare provider institution and was established in 2013, gathering key individuals in the field of clinical genetics that work together towards the development of human genomics research, at both basic and translational levels, with direct impact and benefit of patients and ultimately the healthcare service.

This group aims to understand the importance of heredity and the consequences of genetic disease in the general population, specific ethnic groups, whole families at risk and single individuals. Ongoing research main goals include improvement of the molecular, biochemical and clinical understanding of chromosomal abnormalities, neuromuscular and metabolic disorders, with a focal point in intellectual disabilities. These experimental areas are interlinked and share technological, clinical as well as bioinformatic resources. Complementary to the above a new line of research in bioethics has been recently initiated. In strict collaboration with the more experimental teams, are the clinical collaborators that include Nutrition and Psychology specialists. They will continue to support their patients’ healthcare and their research work in the setting of the Medical Genetics consultations. Researchers are also involved in setting up multidisciplinary education modules for scientific dissemination activities in their expertise area as well as for Clinical Laboratory and Medical Genetics specializations. The organizational structure, involving efforts from multidisciplinary teams, including all medical specialities, allows availability of better procedures, processes simplification and minimizing the resources needed. Overall, CEHG research projects result in a continuing development of the diagnostic trajectory in the endeavour to find more effective treatment and improve genetic counselling.

Group Leader

Paula Jorge

Paula Jorge

Scientific Committee

Members

Luísa Azevedo

Luísa Azevedo

Esmeralda Martins

Esmeralda Martins

Rosário Santos

Rosário Santos

Natália Oliva Teles

Natália Oliva Teles

Celia Azevedo Soares

Celia Azevedo Soares

Nuno Maia

Nuno Maia

  • Genomic investigation of rare genetic disorders, namely inherited metabolic diseases, chromosomal anomalies and neuromuscular disorders, neurodegenerative and neurodevelopmental impairment, lysosomal, peroxisomal and glycosylation disorders.
  • Personalized treatment approaches based on molecular analyses leading to improved clinical outcomes, including the design of alternative healthcare strategies and disclosure of new indications for previously available drugs.
  • To identify and characterize  new syndromes and causative gene(s).
  • To establish disease biomarkers towards a more precise diagnosis.
  • To develop and implement new diagnostic tests to screen for genetic disorders.

UMIB may use cookies to memorise the data you use when logging to website, gather statistics to optimise the functionality of the website and to carry out marketing campaigns based on your interests.

Only necessary Cookies These cookies are essential to provide services available on our website and to enable you to use certain features on our website. Without these cookies, we cannot provide certain services on our website.

Functionality cookies These cookies are used to provide you with a more personalized experience on our website and to remember the choices you make when using our website. For example, we may use functionality cookies to remember your language preferences and/or your login details.

Measuring and performance cookies These cookies are used to collect information to analyze traffic on our website and understand how visitors are using our website. For example, these cookies can measure factors such as time spent on the site or pages visited, this will allow us to understand how we can improve our site for users. The information collected through these measurement and performance cookies does not identify any individual visitor.